The FSA Spy market buzz – 16 May 2025
Playing monopoly with ETFs; Eastspring is worrying about loss aversion; Family office explosion; SGX wants more action; The Fear and Greed Index; Retail investors plough on; Deepfake fraud and much more.
Global emerging market equities did well in 2017 and were one of the best performing markets during the year, according to Lena Tsymbaluk, London-based analyst for manager research at Morningstar.
In 2017, the MSCI Emerging Markets Index returned 27.91% and outperformed the MSCI All Country World Index (24.62%), according to FE data.
But year-to-date the EM index is flat (0.31%) and it has underperformed the MSCI AC World (1.82%). Investors appear to be turning cautious on emerging markets, especially since valuations have gone up, Tsymbaluk said.
However, on the buy side, data collected by FSA shows an increased interest in global emerging markets from fund selectors in Asia. Fund Selector Asia Asset Class Research shows that 60% of respondents said they would add global emerging markets to their allocation in the next 12 months, compared to only 37% in December.
Against this backdrop, FSA compares two global emerging markets equity funds: the Fidelity Emerging Markets Fund and the M&G Global Emerging Markets Fund.
Playing monopoly with ETFs; Eastspring is worrying about loss aversion; Family office explosion; SGX wants more action; The Fear and Greed Index; Retail investors plough on; Deepfake fraud and much more.
Part of the Mark Allen Group.